Europlasma Statistics

Total Valuation

Europlasma has a market cap or net worth of EUR 4.09 million. The enterprise value is 9.46 million.

Market Cap	4.09M
Enterprise Value	9.46M

Important Dates

The next estimated earnings date is Friday, April 25, 2025.

Earnings Date	Apr 25, 2025
Ex-Dividend Date	n/a

Share Statistics

Europlasma has 278.20 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	278.20M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.17
PB Ratio	0.70
P/TBV Ratio	0.64
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.94
EV / Sales	0.40
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.04

Financial Position

The company has a current ratio of 0.74, with a Debt / Equity ratio of 1.32.

Current Ratio	0.74
Quick Ratio	0.31
Debt / Equity	1.32
Debt / EBITDA	n/a
Debt / FCF	-0.85
Interest Coverage	-4.73

Financial Efficiency

Return on equity (ROE) is -370.63% and return on invested capital (ROIC) is -130.70%.

Return on Equity (ROE)	-370.63%
Return on Assets (ROA)	-22.00%
Return on Invested Capital (ROIC)	-130.70%
Return on Capital Employed (ROCE)	-79.62%
Revenue Per Employee	129,679
Profits Per Employee	-54,924
Employee Count	184
Asset Turnover	0.38
Inventory Turnover	1.02

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -99.40% in the last 52 weeks. The beta is 731.19, so Europlasma's price volatility has been higher than the market average.

Beta (5Y)	731.19
52-Week Price Change	-99.40%
50-Day Moving Average	0.01
200-Day Moving Average	0.10
Relative Strength Index (RSI)	48.67
Average Volume (20 Days)	64,224,345

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Europlasma had revenue of EUR 23.86 million and -10.11 million in losses. Loss per share was -45.28.

Revenue	23.86M
Gross Profit	11.36M
Operating Income	-22.07M
Pretax Income	-10.35M
Net Income	-10.11M
EBITDA	-12.97M
EBIT	-22.07M
Loss Per Share	-45.28

Full Income Statement

Balance Sheet

The company has 1.57 million in cash and 7.68 million in debt, giving a net cash position of -6.11 million or -0.02 per share.

Cash & Cash Equivalents	1.57M
Total Debt	7.68M
Net Cash	-6.11M
Net Cash Per Share	-0.02
Equity (Book Value)	5.82M
Book Value Per Share	2.89
Working Capital	-10.63M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -7.61 million and capital expenditures -1.47 million, giving a free cash flow of -9.08 million.

Operating Cash Flow	-7.61M
Capital Expenditures	-1.47M
Free Cash Flow	-9.08M
FCF Per Share	-0.03

Full Cash Flow Statement

Margins

Gross margin is 47.62%, with operating and profit margins of -92.48% and -42.35%.

Gross Margin	47.62%
Operating Margin	-92.48%
Pretax Margin	-43.37%
Profit Margin	-42.35%
EBITDA Margin	-54.34%
EBIT Margin	-92.48%
FCF Margin	n/a

Dividends & Yields

Europlasma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-247.12%
FCF Yield	-222.03%

Stock Splits

The last stock split was on May 28, 2024. It was a reverse split with a ratio of 0.0002.

Last Split Date	May 28, 2024
Split Type	Reverse
Split Ratio	0.0002

Scores

Europlasma has an Altman Z-Score of -5.22. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.22
Piotroski F-Score	n/a